Trials / Completed
CompletedNCT00406497
Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation
Phase 2a Study of 0.05% Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 24 (planned)
- Sponsor
- Sirion Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this phase 2 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of postoperative inflammation.
Detailed description
The objective is to assess efficacy endpoints in comparison with 0.1% BM ophthalmic solution, prior to investigation of the efficacy and safety of 0.05% DFBA ophthalmic emulsion in the treatment of postoperative intraocular inflammation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Difluprednate Ophthalmic Emulsion |
Timeline
- Start date
- 2003-04-01
- Completion
- 2003-07-01
- First posted
- 2006-12-04
- Last updated
- 2006-12-04
Source: ClinicalTrials.gov record NCT00406497. Inclusion in this directory is not an endorsement.